TY - JOUR
T1 - The MEMORY Study
T2 - MulticentEr study of Minimally invasive surgery versus Open Radical hYsterectomy in the management of early-stage cervical cancer: Survival outcomes
AU - Leitao, Mario M.
AU - Zhou, Qin C.
AU - Brandt, Benny
AU - Iasonos, Alexia
AU - Sioulas, Vasileios
AU - Lavigne Mager, Katherine
AU - Shahin, Mark
AU - Bruce, Shaina
AU - Black, Destin R.
AU - Kay, Carrie G.
AU - Gandhi, Meeli
AU - Qayyum, Maira
AU - Scalici, Jennifer
AU - Jones, Nathaniel L.
AU - Paladugu, Rajesh
AU - Brown, Jubilee
AU - Naumann, R. Wendel
AU - Levine, Monica D.
AU - Mendivil, Alberto
AU - Lim, Peter C.
AU - Kang, Elizabeth
AU - Cantrell, Leigh A.
AU - Sullivan, Mackenzie W.
AU - Martino, Martin A.
AU - Kratz, Melissa K.
AU - Kolev, Valentin
AU - Tomita, Shannon
AU - Leath, Charles A.
AU - Boitano, Teresa K.L.
AU - Doo, David W.
AU - Feltmate, Colleen
AU - Sugrue, Ronan
AU - Olawaiye, Alexander B.
AU - Goldfeld, Ester
AU - Ferguson, Sarah E.
AU - Suhner, Jessa
AU - Abu-Rustum, Nadeem R.
N1 - Funding Information:
Drs. Leitao, Iasonos, and Abu-Rustum are supported in part through the NIH/NCI Cancer Center Support Grant P30 CA008748 .
Publisher Copyright:
© 2022 Elsevier Inc.
PY - 2022/9
Y1 - 2022/9
N2 - Objective: The Laparoscopic Approach to Cervical Cancer (LACC) trial found that minimally invasive radical hysterectomy compared to open radical hysterectomy compromised oncologic outcomes and was associated with worse progression-free survival (PFS) and overall survival (OS) in early-stage cervical carcinoma. We sought to assess oncologic outcomes at multiple centers between minimally invasive (MIS) radical hysterectomy and OPEN radical hysterectomy. Methods: This is a multi-institutional, retrospective cohort study of patients with 2009 FIGO stage IA1 (with lymphovascular space invasion) to IB1 cervical carcinoma from 1/2007–12/2016. Patients who underwent preoperative therapy were excluded. Squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinomas were included. Appropriate statistical tests were used. Results: We identified 1093 cases for analysis—715 MIS (558 robotic [78%]) and 378. OPEN procedures. The OPEN cohort had more patients with tumors >2 cm, residual disease in the hysterectomy specimen, and more likely to have had adjuvant therapy. Median follow-up for the MIS and OPEN cohorts were 38.5 months (range, 0.03–149.51) and 54.98 months (range, 0.03–145.20), respectively. Three-year PFS rates were 87.9% (95% CI: 84.9–90.4%) and 89% (95% CI: 84.9–92%), respectively (P = 0.6). On multivariate analysis, the adjusted HR for recurrence/death was 0.70 (95% CI: 0.47–1.03; P = 0.07). Three-year OS rates were 95.8% (95% CI: 93.6–97.2%) and 96.6% (95% CI: 93.8–98.2%), respectively (P = 0.8). On multivariate analysis, the adjusted HR for death was 0.81 (95% CI: 0.43–1.52; P = 0.5). Conclusion: This multi-institutional analysis showed that an MIS compared to OPEN radical hysterectomy for cervical cancer did not appear to compromise oncologic outcomes, with similar PFS and OS.
AB - Objective: The Laparoscopic Approach to Cervical Cancer (LACC) trial found that minimally invasive radical hysterectomy compared to open radical hysterectomy compromised oncologic outcomes and was associated with worse progression-free survival (PFS) and overall survival (OS) in early-stage cervical carcinoma. We sought to assess oncologic outcomes at multiple centers between minimally invasive (MIS) radical hysterectomy and OPEN radical hysterectomy. Methods: This is a multi-institutional, retrospective cohort study of patients with 2009 FIGO stage IA1 (with lymphovascular space invasion) to IB1 cervical carcinoma from 1/2007–12/2016. Patients who underwent preoperative therapy were excluded. Squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinomas were included. Appropriate statistical tests were used. Results: We identified 1093 cases for analysis—715 MIS (558 robotic [78%]) and 378. OPEN procedures. The OPEN cohort had more patients with tumors >2 cm, residual disease in the hysterectomy specimen, and more likely to have had adjuvant therapy. Median follow-up for the MIS and OPEN cohorts were 38.5 months (range, 0.03–149.51) and 54.98 months (range, 0.03–145.20), respectively. Three-year PFS rates were 87.9% (95% CI: 84.9–90.4%) and 89% (95% CI: 84.9–92%), respectively (P = 0.6). On multivariate analysis, the adjusted HR for recurrence/death was 0.70 (95% CI: 0.47–1.03; P = 0.07). Three-year OS rates were 95.8% (95% CI: 93.6–97.2%) and 96.6% (95% CI: 93.8–98.2%), respectively (P = 0.8). On multivariate analysis, the adjusted HR for death was 0.81 (95% CI: 0.43–1.52; P = 0.5). Conclusion: This multi-institutional analysis showed that an MIS compared to OPEN radical hysterectomy for cervical cancer did not appear to compromise oncologic outcomes, with similar PFS and OS.
KW - Cervical cancer
KW - LACC
KW - Laparoscopic Approach to Cervical Cancer trial
KW - Minimally invasive radical hysterectomy
KW - Radical hysterectomy
UR - http://www.scopus.com/inward/record.url?scp=85134781529&partnerID=8YFLogxK
U2 - 10.1016/j.ygyno.2022.07.002
DO - 10.1016/j.ygyno.2022.07.002
M3 - Article
AN - SCOPUS:85134781529
SN - 0090-8258
VL - 166
SP - 417
EP - 424
JO - Gynecologic Oncology
JF - Gynecologic Oncology
IS - 3
ER -